The 4G/5G polymorphism of PAI-1 promoter gene and the risk of myocardial infarction: A meta-analysis

被引：0
|
作者：
Iacoviello, L [1 ]
Burzotta, F
Di Castelnuovo, A
Zito, F
Marchioli, R
Donati, MB
机构：
[1] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Angela Valenti Lab Thrombosis Pharmacol, Dept Vasc Med & Pharm,Un Gen Vasc Risk Fact, I-66030 Santa Maria Imbaro, Italy
[2] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Dept Clin Pharmacol & Epidemiol, Lab Clin Epidemiol Cardiovasc Dis, I-66030 Santa Maria Imbaro, Italy
[3] TNO, PG, Gaubius Lab, Leiden, Netherlands
来源：
THROMBOSIS AND HAEMOSTASIS | 1998年 / 80卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1029 / 1030
页数：2
相关论文
共 50 条
  • [21] 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis
    Sartori, MT
    Wiman, B
    Vettore, S
    Dazzi, F
    Girolami, A
    Patrassi, GM
    THROMBOSIS AND HAEMOSTASIS, 1998, 80 (06) : 956 - 960
  • [22] The-675 4G/5G polymorphism in the PAI-1 gene may not contribute to the risk of PCOS
    Zhang, T. -T.
    Yuan, L.
    Yang, Y. -M.
    Ren, Y.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2014, 18 (16) : 2326 - 2331
  • [23] A rapid detection method for PAI-1 promoter insertion/deletion polymorphism (4G/5G)
    Annichino-Bizzacchi, JM
    Pugliese, L
    Arruda, VR
    GENETICS AND MOLECULAR BIOLOGY, 1998, 21 (03) : 315 - 316
  • [24] PAI-1 4G/5G polymorphism detection and obstetric complications
    Gumpel, C.
    Fornasiero, L.
    Suarez, S.
    Santillan, G.
    Colabianchi, J.
    THROMBOSIS RESEARCH, 2009, 123 : S148 - S148
  • [25] Diabetic microangiopathy and 4G/5G polymorphism of the PAI-1 gene promoter in type 1 diabetic patients.
    Pucci, L
    Pilo, M
    Bandinelli, S
    Navalesi, R
    Penno, G
    DIABETOLOGIA, 1999, 42 : A316 - A316
  • [26] Distribution of PAI-1 promoter 4G/5G polymorphism in Chinese and expression of luciferase reporter vector containing PAI-1 promoter.
    Ding, ZR
    Pan, JQ
    Li, XR
    BLOOD, 2000, 96 (11) : 72B - 72B
  • [27] Distribution of 4G/5G polymorphism in the promoter region of PAI-1 gene in myocardial infarction patients and two control groups of St. Petersburg, Russia
    Volkova, M
    Molchanov, O
    Vasina, V
    Fomicheva, E
    Solovieva, D
    Khavinson, V
    Schwartz, E
    EUROPEAN JOURNAL OF HUMAN GENETICS, 1998, 6 : 127 - 127
  • [28] Attenuation of PAI-1 synthesis by troglitazone in human arterial smooth muscle cells is affected by the 4g/5g polymorphism in the promoter of the PAI-1 gene
    Nordt, TK
    Eschenfelder, E
    Peter, K
    Sobel, BE
    Bode, C
    CIRCULATION, 2000, 102 (18) : 47 - 47
  • [29] THE 4G/5G GENETIC-POLYMORPHISM IN THE PROMOTER OF THE PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) GENE IS ASSOCIATED WITH DIFFERENCES IN PLASMA PAI-1 ACTIVITY BUT NOT WITH RISK OF MYOCARDIAL-INFARCTION IN THE ECTIM STUDY
    YE, S
    GREEN, FR
    SCARABIN, PY
    NICAUD, V
    BARA, L
    DAWSON, SJ
    HUMPHRIES, SE
    EVANS, A
    LUC, G
    CAMBOU, JP
    ARVEILER, D
    HENNEY, AM
    CAMBIEN, F
    THROMBOSIS AND HAEMOSTASIS, 1995, 74 (03) : 837 - 841
  • [30] Association of plasminogen activator inhibitor-1 (PAI-1) gene promoter 4G/5G polymorphism with plasma PAI-1 level in patients with hypertension
    Jeng, JR
    Harn, HJ
    Shieh, SM
    ATHEROSCLEROSIS, 1999, 144 : 64 - 64
12345